HOME >> BIOLOGY >> NEWS
Moderate alcohol consumption increases plasma levels of a protective hormone

  • Moderate alcohol consumption is believed to have protective cardiovascular health benefits, possibly through its effects on hormones.
  • Researchers examine alcohol's effect on three hormones: dehydroepiandrosterone sulfate (DHEAS), testosterone and estradiol.
  • Moderate alcohol consumption appears to increase plasma DHEAS levels for both men and women.

Moderate alcohol consumption is known to have positive, possibly even protective, cardiovascular health effects. A study in the May issue of Alcoholism: Clinical & Experimental Research investigates the role that certain hormones may play in the cardiovascular benefits of alcohol, specifically, dehydroepiandrosterone sulfate (DHEAS), testosterone and estradiol. Researchers found that moderate alcohol consumption can increase plasma DHEAS levels for both men and women, decrease plasma testosterone among men, and has no effect on plasma estradiol levels.

"DHEAS is believed to play a protective role against atherosclerosis in both genders," said Henk F.J. Hendriks, a senior scientist at TNO Nutrition and Food Research in The Netherlands and corresponding author for the study, "just like low testosterone does for men." Atherosclerosis is characterized by irregularly distributed lipid deposits in the arteries, which can provoke fibrosis and calcification, impede blood flow, and/or eventually shut off blood flow. "This is the first diet-controlled intervention study which shows that moderate alcohol drinking can increase DHEAS," he added.

"Estradiol, or estrogens in general," Hendriks continued, "may be pivotal in the protection from coronary heart disease in premenopausal women. An association between moderate alcohol consumption and breast cancer has been proposed, which may be mediated through an increase in estradiol."

"A lot of the earlier work in this area looked at hormones because of associations that had been found between alcohol and breast canc
'"/>


13-May-2004


Page: 1 2 3

Related biology news :

1. Moderate iron deficiency affects cognitive performance - but iron supplementation improves it
2. Moderate alcohol consumption after meals can decrease levels of insulin
3. Moderate alcohol consumption during pregnancy is risky too
4. Moderate vitamin E supplementation may lower diabetics cardiovascular risk
5. Moderate alcohol consumption increases bone mineral density in elderly women
6. Moderate alcohol consumption may reduce your chances of a heart attack
7. Moderate caffeine use does not increase miscarriage risk but high caffeine use doubles risk
8. Duke Researchers Finds That Moderate Caffeine Use Boosts Blood Pressure, Potential For Heart Disease
9. Even Moderate Air Pollution Reaching Eastern Wilderness Decreases Mountain Hikers Lung Function
10. No Such Luck: Nitrogen From Air Pollution Unlikely to Moderate Global Warming
11. A liking for sweets, combined with novelty seeking, may predict alcoholism

Post Your Comments:
(Date:6/17/2015)... Deutschland und GERMANTOWN, Maryland , June ... ®   Produktlinie mit DNA-Tests verbessert den ... (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) hat ... STR-Testkits der Produktlinie Investigator ® ... Markt eingeführt. Die neuen Kits zur Erstellung genetischer Fingerabdrücke ...
(Date:6/16/2015)... , June 16, 2015  With the increasing ... security remains a top concern. The recent compromise of ... the need for strong authentication within government agencies. ... a biometric one-time password (OTP) authenticator, has been submitted ... (FIPS) 140-2 Level 3 validation for tamper proofing. ...
(Date:6/15/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces that its leading payment security technology, the ... Experience! @ NYC June 18th. Digital Experience! @ ... in technology to over 300 of the top media covering ... Pavilion in New York City from ...
Breaking Biology News(10 mins):QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
(Date:7/1/2015)... 1, 2015   Decision Resources Group ... of Otezla are its oral administration, alternative mechanism ... by surveyed rheumatologists. Otezla was the first oral ... of active psoriatic arthritis in the ... care includes conventional oral treatments including disease-modifying antirheumatic ...
(Date:7/1/2015)... July 1, 2015  Axovant Sciences Ltd. (NYSE: ... the treatment of dementia, today announced that the ... 22 at 5:45 p.m. EDT following its presentation ... International Conference 2015 (AAIC). The ... , Dr. Lawrence Friedhoff , Chief Development ...
(Date:7/1/2015)... ... July 01, 2015 , ... Apex Therapeutics announced today that company ... Philadelphia, PA. , The presentation took place on Tuesday, June 16 and ... the development of APX3330 for the treatment of pancreatic cancer. A copy of ...
(Date:6/30/2015)... ... June 30, 2015 , ... Students and faculty from ... first half of “Integrative Biotechnology,” an applied biotechnology course team-taught by faculty members ... course combines students from both universities and is taught on both continents. , ...
Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
Cached News: